Rapidly absorbed liquid compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S568000, C514S849000, C514S853000

Reexamination Certificate

active

07060730

ABSTRACT:
The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred embodiment employs pseudoephedrine and ibuprofen.

REFERENCES:
patent: 4479956 (1984-10-01), Sunshine et al.
patent: 4486436 (1984-12-01), Sunshine et al.
patent: 4522826 (1985-06-01), Sunshine et al.
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4567183 (1986-01-01), Sunshine et al.
patent: 4585783 (1986-04-01), Sunshine et al.
patent: 4587249 (1986-05-01), Sunshine et al.
patent: 4656177 (1987-04-01), Sunshine et al.
patent: 4749711 (1988-06-01), Sunshine et al.
patent: 4749721 (1988-06-01), Sunshine et al.
patent: 4749722 (1988-06-01), Sunshine et al.
patent: 4783465 (1988-11-01), Sunshine et al.
patent: 4839354 (1989-06-01), Sunshine et al.
patent: 4871733 (1989-10-01), Sunshine et al.
patent: 4883818 (1989-11-01), Sunshine et al.
patent: 4923898 (1990-05-01), Sunshine et al.
patent: 4962124 (1990-10-01), Sunshine et al.
patent: 4975426 (1990-12-01), Sunshine et al.
patent: 4980375 (1990-12-01), Sunshine et al.
patent: 4985459 (1991-01-01), Sunshine et al.
patent: 4990535 (1991-02-01), Cho et al.
patent: 5025019 (1991-06-01), Sunshine et al.
patent: 5075114 (1991-12-01), Roche
patent: 5100918 (1992-03-01), Sunshine et al.
patent: 5215755 (1993-06-01), Roche et al.
patent: 5286751 (1994-02-01), Sunshine et al.
patent: 5296233 (1994-03-01), Batista et al.
patent: 5373022 (1994-12-01), Fawzi et al.
patent: 5374659 (1994-12-01), Gowan, Jr.
patent: 5385941 (1995-01-01), Fawzi et al.
patent: 5576311 (1996-11-01), Guy
patent: 5582838 (1996-12-01), Rork et al.
patent: 5597583 (1997-01-01), Grattan
patent: 5621005 (1997-04-01), Gowan, Jr.
patent: 5641512 (1997-06-01), Cimiluca
patent: 5674522 (1997-10-01), Shah et al.
patent: 5712310 (1998-01-01), Koch
patent: 5718919 (1998-02-01), Ruddy et al.
patent: 5759579 (1998-06-01), Singh et al.
patent: 5834479 (1998-11-01), Mayer et al.
patent: 5840768 (1998-11-01), Selinger et al.
patent: 5981591 (1999-11-01), Deihl
patent: 6005005 (1999-12-01), Stroppolo et al.
patent: 6017932 (2000-01-01), Singh et al.
patent: 6132758 (2000-10-01), Munayyer et al.
patent: 6211246 (2001-04-01), Gelotte et al.
patent: 6231890 (2001-05-01), Naito et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: 2001/0005729 (2001-06-01), Gelotte et al.
patent: 0856310 (1998-05-01), None
patent: WO 92/15332 (1992-09-01), None
patent: WO 92/17171 (1992-10-01), None
patent: WO 95/19759 (1995-07-01), None
patent: WO9632941 (1996-10-01), None
patent: WO 98/24414 (1998-06-01), None
patent: WO 98/38983 (1998-09-01), None
Lemsip Power +, Patient Information Leaflet, Product Literature, 1996.
Dr. S.D. Oliver, “Pharmacokinetics and Clinical Activity of a Soluble Combination of Ibuprofen and Pseudoephedrine” European Journal of Clinical Research (1996) 8:269-280.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Rapidly absorbed liquid compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rapidly absorbed liquid compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapidly absorbed liquid compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3670320

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.